Good evening, J-BOX official store.
On Saturdays and Sundays, it was a warm day for going out. Have you all gone out somewhere?
Well, we will deliver the latest vaccine information.
``The Ministry of Health, Labor and Welfare has announced that it will start delivering about 100,000 doses of the new coronavirus vaccine developed by Novavax in the United States to local governments from the end of May. We have notified you to pre-register the location on the 6th, and will proceed with preparations for a smooth supply prior to the approval or rejection of the vaccine on April 18th.
Each prefecture is required to set up at least one vaccination venue, and the number of allocations will remain small. It will be shipped in two batches, the first batch will start the week of May 23rd and the second batch will start the week of June 6th.
The Novavax vaccine was filed by Takeda Pharmaceutical in December 2021. Takeda will receive the technology transfer and will be in charge of domestic production and distribution. The government has signed a contract with Takeda to receive 150 million doses for roughly one year from the beginning of 2022.
If Novavax is approved, it will be the fourth vaccine in Japan. As there are signs of the re-expansion of the new corona, the government aims to increase vaccine options and accelerate the third vaccination. ”
There was a report that
It is said that deliveries to local governments will begin in late May, but the schedule and the amount of supply in each prefecture are published on the website of the Ministry of Health, Labor and Welfare.
Materials can be found here. (See pages 8 and 9.)
https://www.mhlw.go.jp/content/000927271.pdf
I will quote you.
First, the delivery schedule
Next is the distribution amount of prefectures
Please read the article below about the characteristics of Takeda's vaccine (Novavacs).
https://wish2020.jp/blogs/news/express0331
・Storage and shipping temperature: 2-8°C
・Package: Individual packaging of 1 vial
・Vial size: H: 53mm, D (diameter): 24.5mm
By the way, the vial size of the Moderna vaccine is "H: 50 mm, D (diameter): 24 mm" .
There is only a 0.5mm difference between the diameter of the Takeda vaccine (Novavac) vial and the diameter of the Moderna vaccine vial.
Therefore, our Moderna vaccine vial holder uses sponge with high cushioning properties, so even if there is a difference of 0.5 mm (diameter) , Takeda vaccine (Novavac) can be stored.
In addition, we put the individual packaging of Takeda's vaccine (Novavacs) in our inner bag.
■ Individual package size of Takeda vaccine (Novavacs)
■We made a box of the same size as the individual package of Takeda's vaccine (Novavacs) and verified it: 9 individual packages could be stored.
*The black part on the lower right is the cushioning material.
As verified, our vial holders (Moderna) and inner bags are compatible with Moderna vaccines and Takeda vaccines (Novavacs) at the same time.
Takeda Vaccine (Novavac) is available at medical institutions, etc. (hereinafter referred to as (referred to as the “inoculation implementation institution”). After receiving it, it will be immediately transferred to a refrigerator and kept in the temperature range of 2°C to 8°C . Keep in mind that As long as the handling of each vaccine is clearly differentiated, it will be possible for a single vaccination institution to handle both the Takeda vaccine (Novavacs) and other types of COVID-19 vaccines. In that case, take the following measures by clearly distinguishing between the Takeda vaccine (Novavac) and other types of novel coronavirus vaccines, and then pay sufficient attention to inoculation, management, operation, etc. , care must be taken not to inoculate by mistake.
We do not accept subdivision or transfer, but we would like you to consider our products for storage and transfer within the inoculation institution.
Products related to Takeda Vaccine (Novavac):
https://wish2020.jp/collections/bio-mission-option
Thank you for reading.
Stay tuned for next time! !
*Please note that this information is subject to change as it was created based on information prior to regulatory approval.